approaches may be used to quantify costs and benefits. One common valuation approach
is to evaluate the effect of the consequences on production factors. By applying this
approach, the costs of an injury to a human being can be derived by considering the length
of hospitalization and its costs, the degree of permanent disability, and the lost earnings
due to this disability (see Chapter 9 for further details). Another valuation approach is
based on the creation of a hypothetical market for a reduced probability of occurrence,
consequence or risk, and then establishing the price individuals are willing to pay to reduce
these factors. Several other valuation approaches exist, but it is outside the scope of this
chapter to go into these in detail. However, most valuation approaches have in common
that they result in a monetary cost of a fatality, pollution to the environment, etc. It may
seem ‘heartless’, for exampl e, to calculate/estimate the monetary benefits of averting
a fatality because this is associated with identifying the ‘value’ of a human life. Such
considerations are apparent, but some sort of criterion is necessary when analysing risk
exposure to humans as well as property and the environment. Setting no value on the costs
related to a fatality may in the worst case be counter-productive in the process of reducing
the risks associated with activities and the operation of systems.
10.6.4 A daptation onto a Com mon Scale
Different risk control measures result in differen t risk reductions, and each measure is
associated with a set of distinct benefits and costs. In order to select the most cost-effective
measures for implementation, it is very advantageous to evaluate these against each other
on a common scale, which normally implies monetary values. In the previous chapter
several approaches for cost-benefit analysis (CBA) of risk control/reduction measures
were presented, and these must be applied wi thin the framework of the FSA. In particular,
the Implied Cost of Averting a Fatality (ICAF) approach/methodology is very much used
in FSAs, and a detailed review of this approach can be found in Chapter 9. In essence,
the ICAF methodology estimates the achieved risk reduction in terms of cost using the
following equation:
ICAF ¼
Net annual cost of measure
Reduction in annual fatality rate
ð10:1Þ
ICAF may also be calculated by dividing the net present value of all costs for the whole
lifetime of the safety measure by the total reduction in fatalities for that particular period of
time. The ICAF value can be interpreted as the economic benefits of averting a fatality. A
decision criterion must be established for this value in order to evaluate whether a given risk
control option/measure is cost-effective or not. A method for developing such a criterion is
also presented in the previous chap ter. Risk control measures with an ICAF value less than
the criterion should be considered as cost-effective and therefore implemented.
10.6.5 Evaluating Uncertainty
There are always uncertainties involved in a cost-benefit analysis (CBA), especi ally in the
process of identifying and quantifying costs and benefit. The uncertainties must be taken
30 0 CHAPTER 1 0 FORMAL SA FETY ASSESSMENT